Neoadjuvant cytokine (IRX-2) immunotherapy for resectable oral cavity carcinoma: Final results of the INSPIRE trial by Wolf, Gregory T., Bellile, Emily, Mauquoi, Celine, Nguyen, Ariane, Sartor, Maureen, Liu, Siyu, Rozek, Laura, McHugh, Jonathan B., Moyer, Jeff, Patel, Mihir, Saba, Nabil, Erman, Audrey, Martins, Wanessa A., Newman, Jason G., Kaplan, Michael, Oliveira, Frabicio, Victorina, Ana Paula, Bell, R. Bryan, Girotto, Gustavo C., Nieva, Jorge, Valentino, Joseph, Krempl, Greg, Cernea, Claudio R., Kraus, Dennis, Higgins, Kevin, Cruz, Felipe JSM, Panwar, Aru, Campos, Clodoaldo Z., McCaul, Jim

Get full text